Skip to main content

August 2022

academics

 

Clinical research courses

Zydus initiates Phase IV clinical trial for Desidustat

Zydus Lifesciences initiates Phase IV clinical trial for Desidustat in patients with Chronic Kidney Disease (CKD) induced anemia.

Desidustat sold under a brand name Oxemia which is a prescription drug approved in India for patients with Chronic Kidney Disease (CKD) induced anemia, and can be taken only under the advice and guidance of a Nephrologist or an internal medicine specialist.

Hikma launches allergic rhinitis nasal spray in the US

Hikma Pharmaceuticals and Glenmark Specialty S.A., a subsidiary of Glenmark Pharma launches Ryaltris in the US. It is a combination of olopatadine hydrochloride and mometasone furoate and formulated as a nasal spray. Ryaltris is approved by the US Food and Drug Administration (FDA) for the treatment of symptoms of seasonal allergic rhinitis (SAR) in adult and pediatric patients 12 years of age and older.

Applications are invited for post of Project Scientist at Anna University

Anna University was established on 4th September, 1978 as a unitary type of University. This University was named after Late Dr.C.N.Annadurai, former Chief Minister of Tamil Nadu. It offers higher education in Engineering, Technology, Architecture and Applied Sciences relevant to the current and projected needs of the society. Besides promoting research and disseminating knowledge gained therefrom, it fosters cooperation between the academic and industrial communities.

Multiple Openings for M.Pharm, B.Pharm, M.Sc at Pinnacle Life Science | Walk in

Pinnacle Life Science is a 100% subsidiary of India’s most trusted pharmaceutical company Aarti Drugs Ltd (ADL) and forms part of $ 1.5 billion conglomerate of the esteemed Aarti Group of Industries.  With 35 years of healthcare commitment through Aarti Drugs, Pinnacle has made its presence in nearly 90+ countries. Treading carefully on the path of efficient healthcare, the state-of-the-art manufacturing facility is designed to produce formulations that meet international quality standards and stringent regulatory compliances to trade beyond borders.

M.Pharm, MSc, M.Tech Job as Senior Research Fellow at DPSRU - Pay Rs. 35,000 pm

Delhi Pharmaceutical Sciences and Research University (DPSRU) is the first Pharmacy University in India and third in the world, established by Act 07 of 2008 State legislature of Delhi and functional from 2015. It is 100% grant-in-aid State Government University recognized under 2f and Section 22 of the UGC. The University has the legacy of 57 years starting with the D. Pharm.

Drug Safety Associate Require at Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Technology and Operations services, and Accenture Song all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers.

Post : Drug Safety Associate

Dr Mansukh Mandaviya urges Industries to bring innovative research

Union Minister of Chemical and Fertilizers, Dr. Mansukh Mandaviya urges pharma industries to produce medicines and bring innovative research with the goal of ensuring good health and well-being of the people, not only for commercial purpose.

Lupin Receives Tentative Approval from USFDA for Dasatinib Tablets

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Artificial Intelligence Improves Treatment in Women with Heart Attacks

Heart attacks in women are more likely to be fatal than in men. The reasons are differences in age and in comorbidity burden which makes risk assessment in women a challenge. Researchers at the University of Zurich have now developed a novel artificial-intelligence-based risk score that improves personalized care for female patients with heart attacks.

Sugar Disrupts Microbiome, Eliminates Protection Against Obesity and Diabetes

A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.

The findings, published today in Cell(link is external and opens in a new window), suggest that diet matters, but an optimal microbiome is equally important for the prevention of metabolic syndrome, diabetes, and obesity.
Diet alters microbiome.